Back

Subcutaneous implantable cardioverter-defibrillator infection affecting deep tissues: is it always mandatory to remove the device?

EP Europace Journal

24 March 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Rodolfo San Antonio
Rodolfo San Antonio

Author

University Hospital Bellvitge Barcelona , Spain

Margarida Pujol-López
Margarida Pujol-López

Author

Eduard Guasch
Eduard Guasch

Author

Lluís Mont
Lluís Mont

Author

José María Tolosana
José María Tolosana

Author

Hospital Clinic of Barcelona Barcelona , Spain

You may be interested in
thumbnail
Congress Presentation
If it doesn't work, try it different: a subcutaneous implantable cardioverter defibrillator infection case report.
1 April 2025
thumbnail
Congress Presentation
Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.
24 April 2021
thumbnail
Webinar
Pacemaker and defibrillator emergencies
19 September 2023
thumbnail
Congress Presentation
Incidence and risk factors of cardiac implantable electronic device infection in present clinical settings in a Turkish population: A 10-year single-center observational research.
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources